IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine

by Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft
Published 2019-01-01

A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a m...

by Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft
Published 2018-05-01

Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth co...

by Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft
Published 2019-01-01

The era of bioengineering: how will this affect the next generation of cancer immunotherapy?

by Michele Graciotti, Cristiana Berti, Harm-Anton Klok, Lana Kandalaft
Published 2017-06-01

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

by Silvia Martin Lluesma, Michele Graciotti, Cheryl Lai-Lai Chiang, Lana E. Kandalaft
Published 2018-11-01

Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform

by Rita Ahmed, Isaac Crespo, Sandra Tuyaerts, Amel Bekkar, Michele Graciotti, Ioannis Xenarios, Lana E. Kandalaft
Published 2020-01-01

Malaria protein kinase CK2 (PfCK2) shows novel mechanisms of regulation.

by Michele Graciotti, Mahmood Alam, Lev Solyakov, Ralf Schmid, Glenn Burley, Andrew R Bottrill, Christian Doerig, Paul Cullis, Andrew B Tobin
Published 2014-01-01

Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines

by Michele Graciotti, Fabio Marino, HuiSong Pak, Petra Baumgaertner, Anne-Christine Thierry, Johanna Chiffelle, Marta A. S. Perez, Vincent Zoete, Alexandre Harari, Michal Bassani-Sternberg, Lana E. Kandalaft
Published 2020-06-01